ADAM17, whose expression is in turn regulated by miRNA-145 [166], enhances transforming growth factor-α (TGFα) and epidermal growth factor receptor (EGFR) expression, thus contributing to tumor growth and invasiveness [166]. Here, EGFR is linked to neoplasm.